Today, U.S. Markets are closed for Thanksgiving Day.
On Wednesday, Valeant Pharmaceuticals Intl Inc (NYSE:VRX)’s shares declined -0.51% to $87.00.
VRX has 66.80% institutional ownership while its EPS ratio was 1.77. The company has 341.19 million shares outstanding while market capitalization of the company was $29.71 billion. Price to book ratio was 4.73. Net profit margin of the company was 6.10% while gross profit margin was 75.00%. Stock volatility for the month was booked as 10.32% while for the week was recorded as 10.51%.
Analysts mean recommendation for the stock is 3.00. This number is based on a 1 to 5 scale where 1 indicates a Strong Buy recommendation while 5 represents a Strong Sell.
Valeant Pharmaceuticals International, Inc. is a specialty pharmaceutical and medical device company. The Company is engaged in developing, manufacturing, and marketing a range of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products, and medical devices (contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices), which are marketed directly or indirectly in over 100 countries.
Avon Products, Inc. (NYSE:AVP)’s shares gained 0.60% to $3.33.
So far in 2015, the company has a year-to-date performance of -64.54%. The stock, as of last close, traded 38.17% up from its 52 week low and was -65.89% below its 52 week high. Its latest closing price was -43.33% below the SMA200 while the distance from SMA 50 and SMA 20 was -3.06% and 5.64% respectively.
The mean estimate for the short term price target for Avon Products, Inc. (AVP) stands at $4.67 according to 10 Analysts. The higher price target estimate for the stock has been calculated at $10.00 while the lower price target estimate is at $2.50.
Analysts mean recommendation for the stock is 3.00. This number is based on a 1 to 5 scale where 1 indicates a Strong Buy recommendation while 5 represents a Strong Sell.
Avon Products, Inc. is a manufacturer and marketer of beauty and related products. The Company’s offers its products under two product categories: Beauty and Fashion & Home. Beauty consists of skincare (which includes personal care), fragrance and color (cosmetics).
At the end of Wednesday’s trade, Ingersoll-Rand PLC (NYSE:IR)‘s shares surged 0.05% to $58.51.
IR has market capitalization of $15.27 billion. Its current ratio was 1.20 while its shares were above its 50 days simple moving average with 4.79%. The company offered earning per share of $2.48 while its 261.05 million shares were outstanding. YTD performance of the company was -7.7%. Stock volatility for the week was 1.32% while for the month it was shown at 1.69%.
The mean estimate for the short term price target for Ingersoll-Rand PLC (IR) stands at $65.60 according to 20 Analysts. The higher price target estimate for the stock has been calculated at $78.00 while the lower price target estimate is at $53.00.
Analysts mean recommendation for the stock is 2.20. This number is based on a 1 to 5 scale where 1 indicates a Strong Buy recommendation while 5 represents a Strong Sell.
Ingersoll-Rand Public Limited Company (IR-Ireland) is a diversified, global company that provides products, services and solutions to improve the quality and comfort of air in homes and buildings, transport and protect food and perishables.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.